Open Clinical Trial Data for All? A View from Regulators | Zendy

HansGeorg Eichler | Zendy; Éric Abadie | Zendy; Alasdair Breckenridge | Zendy; Hubert G.M. Leufkens | Zendy; Guido Rasi | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Open Clinical Trial Data for All? A View from Regulators

Author(s) -

HansGeorg Eichler,

Éric Abadie,

Alasdair Breckenridge,

Hubert G.M. Leufkens,

Guido Rasi

Publication year - 2012

Publication title -

plos medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 4.847

H-Index - 228

eISSN - 1549-1676

pISSN - 1549-1277

DOI - 10.1371/journal.pmed.1001202

Subject(s) - clinical trial , protocol (science) , medicine , european union , raw data , randomized controlled trial , openness to experience , alternative medicine , open data , medline , data science , computer science , business , psychology , surgery , political science , world wide web , law , pathology , social psychology , economic policy , programming language

Hans-Georg Eichler from the European Medicines Agency and colleagues provide a view from regulators on access to clinical trial data.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research